English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

* Abbreviations: IRB — : institutional review board QI — : quality improvementIn this article, we challenge 2 fundamental assumptions underlying the current regulation of research for unproven therapies: (1) current regulatory practices serve the best interests of patients and (2) standard definitions allow clear demarcation and rational regulation of such therapies in clinical practice, research, and quality improvement (QI) activities. Our goal is to prompt serious consideration of how to better serve all patients, not just research participants, treated with unproven therapies. We begin with a depiction of usual perinatal practices in 2009.Dr Smith, an obstetrician in a major hospital, delivers a 27-weeks’ gestation infant who cries at delivery. As part of long-standing clinical practice Dr Smith immediately clamps the umbilical cord. He then hands the infant to Dr Jones, a neonatologist, for additional care. Later that day, Dr Smith performs an emergency caesarian delivery for fetal distress at 38 weeks’ gestation. The infant does not breathe immediately. Dr Jones initiates resuscitation using 100% oxygen, a practice widely recommended for decades. Neither Dr Smith nor Dr Jones had discussed early cord clamping or resuscitation with 100% oxygen as unproven therapies with the parents. Obstetricians and neonatologists in a perinatal center in the same center proposed large randomized trials to assess delayed cord clamping and use of restricted oxygen concentration during resuscitation. However, they abandoned plans for these trials because of difficulty in meeting stringent institutional review board (IRB) requirements for informed consent. Like many other therapies used in clinical practice, neither early cord clamping nor resuscitation with 100% oxygen ever had proven value by current Grading of Recommendations … Address correspondence to Susan H. Wootton, MD, Department of Pediatrics, University of Texas Health Science Center, 6431 Fannin St, MSB 2.106, Houston, TX 77098. E-mail: susan.h.wootton{at}uth.tmc.edu

Unproven Therapies in Clinical Research and Practice: The Necessity to Change the Regulatory Paradigm